UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000019329
Receipt No. R000022354
Scientific Title Examination of the association between type 2 diabetes and sleep disorder by the questionnaire about sleep disorder.
Date of disclosure of the study information 2015/10/13
Last modified on 2022/10/24 (Ver. 7)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Examination of the association between type 2 diabetes and sleep disorder by the questionnaire about sleep disorder.
Acronym Examination of the association between type 2 diabetes and sleep disorder by the questionnaire about sleep disorder.
Scientific Title Examination of the association between type 2 diabetes and sleep disorder by the questionnaire about sleep disorder.
Scientific Title:Acronym Examination of the association between type 2 diabetes and sleep disorder by the questionnaire about sleep disorder.
Region
Japan

Condition
Condition type 2 diabetes
Classification by specialty
Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 For type 2 diabetes patients visiting this hospital,we carry out questionnaires about the sleep. It is intended to grasp a ratio and a kind of a sleep disorder in the type 2 diabetes patients,and consider relations between glucose tolerance and a sleep disorder.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Score of the Pittsburgh Sleep Quality Index
Key secondary outcomes Score of the Eveningness Questionnaire
Score of the sleep disorder screening
HbA1c and fasting blood glucose
Affection period of diabetes
lipid parameters(HDL cholesterol,LDL cholesterol,triglyceride)
body weight,blood pressure,and abdominal circumscription

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria (1)Type 2 diabetes patients
(2)Adalts who are 20 years or older and 80 years or younger.
(3) Patients who can understand consent brief and other explanation documents having the ability of the agreement about participation in this examination
*We take it as an agreement by the collection of the questionnaire which was filled in.
Key exclusion criteria (1) Type 1 diabetes mellitus patients or secondary diabetic mellitus
(2) The patient who has taken a sleeping drug or an antipsychotic drug
(3) In addition, the patients who will be judged inappropriate by an attendant physician
Target sample size 300

Research contact person
Name of lead principal investigator
1st name Takahisa
Middle name
Last name Hirose
Organization Toho University School of Medicine
Division name Divsion of diabetes, metabolism and endocrinology
Zip code 143-8541
Address 6-11-1 Omori-nishi,Ota-ku,Tokyo 143-8541,Japan
TEL 0337624151
Email takahisa.hirose@med.toho-u.ac.jp

Public contact
Name of contact person
1st name Takahisa
Middle name
Last name Hirose
Organization Toho University School of Medicine
Division name Divsion of diabetes, metabolism and endocrinology
Zip code 143-8541
Address 6-11-1 Omori-nishi,Ota-ku,Tokyo 143-8541,Japan
TEL 0337624151
Homepage URL
Email takahisa.hirose@med.toho-u.ac.jp

Sponsor
Institute Toho University School of Medicine
Institute
Department

Funding Source
Organization Toho University School of Medicine
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization ethics committee of Toho University school if medicine
Address 6-11-1 Omori-nashi, Ota-Ku, Tokyo 143-8541, Japan
Tel 0337624151
Email oomori.rinri@ex.toho-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 10 Month 13 Day

Related information
URL releasing protocol DOI: 10.1007/s13340-021-00516-3
Publication of results Published

Result
URL related to results and publications DOI: 10.1007/s13340-021-00516-3
Number of participants that the trial has enrolled 472
Results Younger T2DM patients had poorer sleep quality and higher BMI.
Results date posted
2022 Year 10 Month 24 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics Type 2 diabetes who were attended our department without any symptoms of obstructive sleep apnea and any use of hypnotics.
Participant flow A total of 472 returned the filled questionnaire. Participants who answered insufficiently (n = 66) or met the exclusion criteria (n = 26) were excluded from the analysis. Consequently, the final number of eligible participants was 380.Participants were categorized by age into four groups according to patients who were (1) less than 50 years (< 50), (2) between 50 and 60 years, (3) between 60 and 70 years, and (4) between 70 and 80 years.
Adverse events Not applicable as this is a cohort study.
Outcome measures Comparison of the score of Pittsburgh Sleep Quality Index and the Morning-Evening Questionnaire, Glucose metabolism-related index, anthropometric data between 4 groups.
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 09 Month 28 Day
Date of IRB
2015 Year 09 Month 28 Day
Anticipated trial start date
2015 Year 10 Month 14 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Study design:cohort study
Recruitment of target people: Type 2 diabetes patients who consulted our facilities in from October 2015 through March 2016

Management information
Registered date
2015 Year 10 Month 13 Day
Last modified on
2022 Year 10 Month 24 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000022354